ARS Pharmaceuticals Inc.
SPRY | NASDAQ
$4.35
+$0.24 (+5.84%)
At close: Sep 21, 2026, 4:00 PM ET
$4.48
+$0.13 (+2.99%)
Pre-market:
Sep 22, 2026, 8:53 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 41.32M | 50.82M | 70.97M | 210.52M | 60.06M | 24.52M |
Short-Term Investments | 203.67M | 263.21M | 157.39M | 63.86M | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 25.84M | 8.11M | 801K | 2.96M | 23K | 2K |
Receivables | 26.35M | 9.16M | 795K | n/a | 1K | 384K |
Inventory | 8.37M | 5.21M | n/a | n/a | n/a | n/a |
Other Current Assets | 5.19M | 1.23M | n/a | 1.01M | n/a | n/a |
Total Current Assets | 284.9M | 334.3M | 231.56M | 277.7M | 60.73M | 26.38M |
Property-Plant & Equipment | 2.47M | 1.07M | 824K | 774K | 693K | 23K |
Goodwill & Intangibles | 14.45M | 7.69M | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 42.76M | 16.86M | 1.63M | 3.74M | 716K | 25K |
Total Assets | 327.65M | 351.15M | 233.19M | 281.44M | 61.45M | 26.41M |
Account Payables | 5.73M | 9.87M | 759K | 1.66M | 1.79M | 1.22M |
Deferred Revenue | 609K | 557K | n/a | n/a | 1.46M | 3.52M |
Short-Term Debt | n/a | n/a | 237K | n/a | 3.48M | 2.56M |
Other Current Liabilities | 588K | 2.29M | 1.08M | 1.46M | 660K | n/a |
Total Current Liabilities | 39.15M | 23.44M | 2.39M | 5.44M | 8.19M | 8.21M |
Long-Term Debt | 96.37M | n/a | n/a | n/a | 4.93M | 7.46M |
Other Long-Term Liabilities | 76.75M | 69.38M | n/a | 2.85M | 76.12M | 21.35M |
Total Long-Term Liabilities | 174.25M | 70.92M | 37K | 3.11M | 84.53M | 32.25M |
Total Liabilities | 213.39M | 94.36M | 2.43M | 8.55M | 92.72M | 40.46M |
Total Debt | 96.37M | 42K | 274K | 481K | 9.03M | 10.02M |
Book Value | 114.26M | 256.8M | 230.76M | 272.89M | -31.27M | -14.05M |
Book Value Per Share | 1.16 | 2.51 | 2.42 | 6.83 | -1.08 | -0.40 |
Common Stock | 10K | 10K | 10K | 9K | 3K | 223K |
Retained Earnings | -294.6M | -123.31M | -131.3M | -76.94M | -42.26M | -22.01M |
Comprehensive Income | 125K | 220K | 49K | 407K | n/a | n/a |
Shareholders Equity | 114.26M | 256.8M | 230.76M | 272.89M | -31.27M | -14.05M |
Total Investments | 203.67M | 263.21M | 157.39M | 63.86M | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove SPRY